128 related articles for article (PubMed ID: 1907247)
1. Tissue-specific effects of aldose reductase inhibition on fluorescence and cross-linking of extracellular matrix in chronic galactosemia. Relationship to pentosidine cross-links.
Richard S; Tamas C; Sell DR; Monnier VM
Diabetes; 1991 Aug; 40(8):1049-56. PubMed ID: 1907247
[TBL] [Abstract][Full Text] [Related]
2. Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase.
Nagaraj RH; Prabhakaram M; Ortwerth BJ; Monnier VM
Diabetes; 1994 Apr; 43(4):580-6. PubMed ID: 8138064
[TBL] [Abstract][Full Text] [Related]
3. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
4. Non-tryptophan fluorescence and high molecular weight protein formation in lens crystallins of rats with chronic galactosemia: prevention by the aldose reductase inhibitor sorbinil.
Nagaraj RH; Monnier VM
Exp Eye Res; 1990 Oct; 51(4):411-8. PubMed ID: 2120080
[TBL] [Abstract][Full Text] [Related]
5. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P
Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
[TBL] [Abstract][Full Text] [Related]
6. Collagen browning and cross-linking are increased in chronic experimental hyperglycemia. Relevance to diabetes and aging.
Monnier VM; Sell DR; Abdul-Karim FW; Emancipator SN
Diabetes; 1988 Jul; 37(7):867-72. PubMed ID: 3384185
[TBL] [Abstract][Full Text] [Related]
7. Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy.
Kamijo M; Basso M; Cherian PV; Hohman TC; Sima AA
Diabetes Res Clin Pract; 1994 Sep; 25(2):117-29. PubMed ID: 7821191
[TBL] [Abstract][Full Text] [Related]
8. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
Das A; Frank RN; Zhang NL; Samadani E
Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
[TBL] [Abstract][Full Text] [Related]
9. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.
Vinores SA; Campochiaro PA
Exp Eye Res; 1989 Sep; 49(3):495-510. PubMed ID: 2507341
[TBL] [Abstract][Full Text] [Related]
10. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
[TBL] [Abstract][Full Text] [Related]
11. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
Suárez G; Rajaram R; Bhuyan KC; Oronsky AL; Goidl JA
J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
[TBL] [Abstract][Full Text] [Related]
12. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
Bank N; Coco M; Aynedjian HS
Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
[TBL] [Abstract][Full Text] [Related]
13. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs.
Engerman RL; Kern TS; Larson ME
Diabetologia; 1994 Feb; 37(2):141-4. PubMed ID: 8163047
[TBL] [Abstract][Full Text] [Related]
14. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
Engerman RL; Kern TS
Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
Cohen MP; Klepser H; Wu VY
Gen Pharmacol; 1991; 22(4):603-6. PubMed ID: 1936894
[TBL] [Abstract][Full Text] [Related]
19. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3175-7. PubMed ID: 1748548
[TBL] [Abstract][Full Text] [Related]
20. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]